Bead Biopharma

HoneyBear Biosciences

Honeybear Biosciences develops antibody-drug and antibody-radionuclide conjugates for pharmaceutical and biotechnology companies to treat cancer through its site-specific glycan conjugation platform.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

SynAffix

This company licenses a technology platform for antibody-drug conjugate development to pharmaceutical and biotechnology firms to enable targeted cancer treatments.

LigaChem Biosciences

This biopharmaceutical company develops antibody-drug conjugates and immuno-oncology therapeutics for global pharmaceutical partners and patients with unmet medical needs.

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.